Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial
[DOI] [PubMed] [Google Scholar] 74.Swietach P., Youm J.-B., Saegusa N., Leem C.-H., Spitzer K.W., Vaughan-Jones R.D
Check for transparency about sourcing and manufacturing
The following reagents were also used in our study: 1640 (Gibco, Grand Island, United States), FBS (Gibco, Grand Island, United States), trypsin (Amresco, United States), EDTA (Amresco, United States), ELISA Kit for TNF- and IL-6 (R&D Systems, Minneapolis, United States), Annexin V-FITC/PI Kit (BD, San Jose, United States), APC-conjugated anti-mouse CD8 (BioLegend, San Diego, United States), BV421-conjugated anti-mouse CD86 (BioLegend, San Diego, United States), BV711-conjugated anti-mouse CD64 (BioLegend, San Diego, United States), FITC anti-mouse MERTK Monoclonal Antibody (BioLegend, San Diego, United States), PECY7-conjugated anti-mouse CD11b (BioLegend, San Diego, United States), PE-conjugated anti-mouse CD3 (BioLegend, San Diego, United States), PEconjugated anti-mouse B220 (BioLegend, San Diego, United States), AlexaFluor 594 anti-mouse CD326 (Ep-CAM) Antibody (BioLegend, San Diego, United States), Alexa Fluor 647 mouse anti-Siglec-F (BioLegend, San Diego, United States), eFluor 570 mouse anti-F4/80 (BioLegend, San Diego, United States), eBioscience Fixable Viability Dye eFluor 780 (eBioscience, San Diego, United States), DNase I (Roche, Basel, Switzerland), DTT (MerckRoche, Basel, Switzerland), collagenase IV (Sigma-Aldrich, St
